While operating expenses generally decrease in an acquired hospital and costs remain consistent after such a purchase, prices increase on average about 5 percent for commercially insured patients, according to the report.
Healthcare quality, meanwhile, decreases as measured by higher readmission rates, which are also linked to decreases in personnel numbers post-acquisition.
“This study provides credible evidence to suggest that proposed mergers would raise prices for consumers and employers without increasing quality of care,” the report says.
State regulators could consider requiring mandated quality standards during a preapproval process of any hospital acquisition, the authors suggested.
“This brief highlights that independent hospital mergers have negative consequences for insurers, employers, and consumers,” the report concluded. “As hospital mergers continue to occur at a high rate, it is important that stakeholders understand their implications.”
Further details on the data used in this report can be found here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
